From step Counters to Clinical Tools: How Wearables Are Maturing into VBC Infrastructure
As VBC continues to gain traction, the role of biometric wearables is transforming. What began as consumer tech is ๐ฃ๐ฆ๐ค๐ฐ๐ฎ๐ช๐ฏ๐จ ๐ง๐ฐ๐ถ๐ฏ๐ฅ๐ข๐ต๐ช๐ฐ๐ฏ๐ข๐ญ ๐ต๐ฐ ๐ณ๐ช๐ด๐ฌ-๐ฃ๐ข๐ด๐ฆ๐ฅ ๐ค๐ข๐ณ๐ฆ ๐ฎ๐ฐ๐ฅ๐ฆ๐ญ๐ด.
Wearables are now being integrated into clinical protocols for:
โช๏ธ Chronic disease management
โช๏ธ Behavioral health
โช๏ธ Post-acute monitoring
โช๏ธ Decentralized trials
They provide continuous, passive data capture that supports proactive intervention. Traditional episodic care lacks this kind of real-time visibility, which is increasingly critical to reducing utilization, improving adherence, and enhancing outcomes under VBC contracts.
HHS has signaled that real-time patient monitoring is a national priority, given its potential to improve health outcomes and support care delivery in both rural and underserved settings.
For early-stage companies, expectations now require:
Clinical validation
EMR integration
Scalable patient engagement
Reimbursement readiness
Strategics and investors focus on platforms that align with value-based economics and can demonstrate measurable impact on cost and quality.
At our firm, we view this convergence as one of the most investable areas in healthcare innovation. If you're a founder building sensing and monitoring platforms, we would welcome a conversation.